Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
Androgen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer. Androgen deprivation has been associated with a wide range of iatrogenic effects impacting a variety of body sys...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2012/580306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562799092432896 |
|---|---|
| author | Matthew E. Johnson Mark K. Buyyounouski |
| author_facet | Matthew E. Johnson Mark K. Buyyounouski |
| author_sort | Matthew E. Johnson |
| collection | DOAJ |
| description | Androgen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer. Androgen deprivation has been associated with a wide range of iatrogenic effects impacting a variety of body systems including metabolic, musculoskeletal, cardiovascular, neurocognitive, and sexual. This review aims to provide the radiation oncology community with the knowledge to monitor and manage androgen deprivation therapy toxicity in an effort to provide the highest level of care for patients and to minimize the iatrogenic effects of androgen deprivation as much as possible. |
| format | Article |
| id | doaj-art-3b09b062e9b34e108d91b482f738500a |
| institution | Kabale University |
| issn | 2090-3111 2090-312X |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Prostate Cancer |
| spelling | doaj-art-3b09b062e9b34e108d91b482f738500a2025-02-03T01:21:44ZengWileyProstate Cancer2090-31112090-312X2012-01-01201210.1155/2012/580306580306Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation TherapyMatthew E. Johnson0Mark K. Buyyounouski1Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USADepartment of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USAAndrogen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer. Androgen deprivation has been associated with a wide range of iatrogenic effects impacting a variety of body systems including metabolic, musculoskeletal, cardiovascular, neurocognitive, and sexual. This review aims to provide the radiation oncology community with the knowledge to monitor and manage androgen deprivation therapy toxicity in an effort to provide the highest level of care for patients and to minimize the iatrogenic effects of androgen deprivation as much as possible.http://dx.doi.org/10.1155/2012/580306 |
| spellingShingle | Matthew E. Johnson Mark K. Buyyounouski Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy Prostate Cancer |
| title | Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy |
| title_full | Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy |
| title_fullStr | Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy |
| title_full_unstemmed | Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy |
| title_short | Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy |
| title_sort | androgen deprivation therapy toxicity and management for men receiving radiation therapy |
| url | http://dx.doi.org/10.1155/2012/580306 |
| work_keys_str_mv | AT matthewejohnson androgendeprivationtherapytoxicityandmanagementformenreceivingradiationtherapy AT markkbuyyounouski androgendeprivationtherapytoxicityandmanagementformenreceivingradiationtherapy |